Boston Globe reporter Jeremy Fox memorializes the life and work of Eli Broad, “whose philanthropy enabled the creation of the Broad Institute of MIT and Harvard in Cambridge, one of the most influential scientific research centers in the country.”
Eli Broad, a founder and benefactor of the Broad Institute of MIT and Harvard, has died at age 87, reports William Grimes for The New York Times. Grimes writes that Broad was “a businessman and philanthropist whose vast fortune, extensive art collection and zeal for civic improvement helped reshape the cultural landscape of Los Angeles.”
Boston Globe reporter Andy Rosen writes that the Broad Institute of MIT and Harvard has launched “a new, $300 million initiative that applies advanced computer science to some of the hardest problems in medicine — an endeavor it said could uncover new ways to fight cancer, infectious disease, and other illnesses.”
CBS News spotlights how two MIT researchers have been named to key roles on the Biden administration’s science team. Prof. Eric Lander, president and founding director of the Broad Institute, has been nominated to lead the Office of Science and Technology Policy, and Maria Zuber, MIT’s vice president for research, will co-chair the President's Council of Advisors on Science and Technology. Zuber said she hopes to "restore trust in science, and pursue breakthroughs that benefit all people."
Prof. Eric Lander, president and founding director of the Broad Institute, and Maria Zuber, MIT’s vice president for research, have been nominated to leading roles on the Biden administration's science team, report Nidhi Subbaraman and Alexandra Witze for Nature. “These are excellent appointments, highly qualified and experienced, and well grounded in science,” says Rita Colwell, a professor at University of Maryland at College Park and former director of the National Science Foundation
AP reporter Seth Borenstein writes about how President-elect Joe Biden is nominating Prof. Eric Lander of the Broad Institute to serve as his chief science officer and lead the Office of Science and Technology Policy, and has selected Maria Zuber, vice president for research at MIT, to co-chair the President’s Council of Advisors on Science and Technology. Francis Collins, director of the NIH, called Lander, “brilliant, visionary, exceptionally creative and highly effective in aspiring others. I predict he will have a profound transformational effect on American science.”
New York Times reporter Carl Zimmer writes that Prof. Eric Lander, president and founding director of the Broad Institute, has been nominated to serve as director of the Office of Science and Technology Policy and to serve as a presidential science advisor. MIT Vice President for Research Maria Zuber will co-chair the President’s Council of Advisors on Science and Technology.
Prof. Eric Lander, president and founding director of the Broad Institute, has been nominated by President-elect Joe Biden to lead the Office of Science and Technology Policy, which Biden will make a Cabinet-level position, reports Sarah Kaplan for The Washington Post. Maria Zuber, MIT’s vice president for research, will co-chair the President’s Council of Advisors on Science and Technology.
Research affiliate Fei Chen and his colleagues have developed a new method that could be used to uncover the organization and sequence of DNA inside intact cells, reports Nature. The new method could be used to “help to reveal how genome organization changes with disease.”
Professor Angelika Amon, an award-winning cell biologist and “an advocate for the kinds of studies that grind away outside of the limelight,” died on Oct. 29, reports Bryan Marquard for The Boston Globe. Amon’s daughter, Clara Weis, noted that Amon “was pretty much the best role model there is. She was very caring and understanding. She always knew what was happening and how to deal with it the right way.”
Prof. James Collins speaks with Boston 25 reporter Julianne Lima about the growing issue of antibiotic resistant bacteria and his work using AI to identify new antibiotics. Collins explains that a new platform he developed with Prof. Regina Barzilay uncovered “a host of new antibiotics including one that we call halicin that has remarkable activity against multi drug-resistant pathogens.”
Writing for The Boston Globe, Prof. Eric Lander, president and founding director of the Broad Institute, argues that the U.S. needs to take steps to ensure that "science benefits society and society trusts science…In the 2020s, the decision-making must include a much wider range of people, who will need to be prepared to grapple thoughtfully with hard choices.”
AP reporter Mark Pratt writes that the Broad Institute and Brigham and Women’s Hospital are launching a “six-month study of 10,000 people to help them better understand the prevalence of COVID-19 in the area and to help identify potential surges during the fall and winter.
The Broad Institute and Brigham and Women’s are launching a large-scale research study aimed at testing people for Covid-19 at home, reports Travis Anderson and Emily Sweeney for The Boston Globe. The initiative will “provide information on the prevalence of the virus in the area and could offer an early warning sign of a surge of new cases in the fall and winter,” Sweeney and Anderson explain.
WBUR’s Carey Goldberg chronicles how the Broad Institute of MIT and Harvard is processing over 70,000 Covid-19 tests a day for Massachusetts nursing homes, hot spots and over 100 colleges. Goldberg notes that the Broad’s testing capacity, “is now allowing thousands of college students to be on campus across the region.”